ISDMR.E — Iskenderun Demir ve Celik AS Balance Sheet
0.000.00%
- TRY104.23bn
- TRY98.84bn
- TRY110.44bn
- 65
- 81
- 61
- 84
Annual balance sheet for Iskenderun Demir ve Celik AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 38.6 | 8,825 | 6,509 | 11,568 | 18,969 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8,196 | 2,827 | 4,035 | 9,476 | 9,683 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 12,949 | 25,998 | 31,296 | 57,495 | 69,138 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14,230 | 27,950 | 40,807 | 70,850 | 100,514 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 28,343 | 55,755 | 74,689 | 135,571 | 177,227 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,815 | 8,593 | 13,477 | 37,701 | 29,968 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6,363 | 16,598 | 22,889 | 49,569 | 60,631 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 21,981 | 39,157 | 51,800 | 86,003 | 116,597 |
| Total Liabilities & Shareholders' Equity | 28,343 | 55,755 | 74,689 | 135,571 | 177,227 |
| Total Common Shares Outstanding |